Transfusion-Associated Graft-vs-Host Disease-Reference-Cited by-同舟云学术

Transfusion-Associated Graft-vs-Host Disease

Published:2000-05-01 Issue:5 Volume:113 Page:732-737
ISSN:1943-7722
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:

Author:

Gorman Timothy E.¹,Julius Carmen J.¹,Barth Rolf F.¹,Ng A.²,Kennedy Melanie S.¹,Prior Thomas W.¹,Allen James³,Lasky Larry C.¹

Affiliation:

1. Departments of Pathology, Central Ohio Region, Columbus, OH

2. The American Red Cross, Central Ohio Region, Columbus, OH

3. Internal Medicine, The Ohio State University, Central Ohio Region, Columbus, OH

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/113/5/732/24905527/ajcpath113-0732.pdf

Reference15 articles.

1. Nishimura M, Uchida S, Mitsunaga S, et al. Characterization of T-cell clones derived from peripheral blood lymphocytes of a patient with transfusion-associated graft-versus-host disease: Fas-mediated killing by CD4+ and CD8+ cytotoxic T-cell clones and tumor necrosis factor beta production by CD4+ T-cell clones. Blood. 1997;89: 1440-1445.

2. Przepiorka D, LeParc G, Stovall M, et al. Use of irradiated blood components. Am J Clin Pathol. 1996;106:6-11.

3. Arsura E, Bertelle A, Mindowitz S, et al. Transfusion-associated-graft-vs-host disease in a presumed immunocompetent patient. Arch Intern Med. 1988;148:1941-1944.

4. Bell C. Fatal transfusion-associated graft-versus-host disease caused by blood from an unrelated donor in an immunocompetent patient. Transfusion. 1993;33:785-786.

5. Wagner FF, Flegel WA. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes. Transfusion. 1995;35:284-291.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transfusion-associated graft-vs-host disease – A case report;Acta Haematologica Polonica;2016-10

2. Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation;Transfusion;2015-08-25

3. Benefit of STR-based chimerism analysis to identify TA-GVHD as a cause of death: Utility of various biological specimens;Medicine, Science and the Law;2015-04-06

4. Transfusion associated graft versus host disease;Indian Journal of Dermatology;2015

5. Leukoreduction and ultraviolet treatment reduce both the magnitude and the duration of the HLA antibody response;Transfusion;2013-06-30